Glucagon-like peptide-1 receptor (GLP-1R) agonists: GLP-1R agonists, commonly used in managing diabetes, have shown neuroprotective effects in preclinical and early clinical studies. This evidence concerns the gene GLP1R and diabetes mellitus.